Clinical Trials Directory

Trials / Unknown

UnknownNCT03782675

Air Barrier System for the Reduction of Airborne Colony-forming Units During Total Shoulder Arthroplasty

Air Barrier System for the Reduction of Airborne Particulate and Colony-forming Units (CFU) During Total Shoulder Arthroplasty.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Nimbic Systems, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to determine whether the Air Barrier System device reduces airborne colony-forming units (e.g., bacteria) present at a surgery site during total shoulder arthroplasty surgeries.

Detailed description

The Air Barrier System (ABS) is a device that uses localized clean air flow to shield a surgery site from ambient airborne contamination. This study examines the hypothesis that the ABS can reduce the presence of airborne CFU and particles at the surgery site during total arthroplasty surgery.

Conditions

Interventions

TypeNameDescription
DEVICEControlThe Air Barrier System will be deployed onto the surgical field, but the airflow will not be activated, so this is a sham control comparator.
DEVICEAir Barrier SystemThe Air Barrier System is a device that uses localized clean air flow to shield a surgery site from ambient airborne microorganisms that are shed into the air from people present in the operating room.

Timeline

Start date
2019-02-01
Primary completion
2019-05-01
Completion
2019-07-01
First posted
2018-12-20
Last updated
2018-12-20

Regulatory

Source: ClinicalTrials.gov record NCT03782675. Inclusion in this directory is not an endorsement.

Air Barrier System for the Reduction of Airborne Colony-forming Units During Total Shoulder Arthroplasty (NCT03782675) · Clinical Trials Directory